[ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]

Ross Fiziol Zh Im I M Sechenova. 2017 Feb;103(2):201-8.
[Article in Russian]

Abstract

The effect of the tetrapeptide bronchogen on the structural and functional state of the bronchial epithelium and inflammatory activity in the lungs was studied in the chronic obstructive pulmonary disease (COPD) model, created in rats by a 60-day intermittent exposure to nitrogen dioxide. The cell composition and cytokine-enzyme profile of bronchoalveolar lavage fluid (BALF), the content of secretory immunoglobulin A and surfactant protein B in BALF were determined. Following the course of peptide treatment the decreased activity of neutrophilic inflammation with the normalization of cellular composition and profile of pro-inflammatory cytokines and enzymes in the bronchoalveolar space was observed. The structure of bronchial epithelium, disturbed during formation of COPD model, was restored and accompanied by restoration of its functional activity as evidenced by an increase of secretory immunoglobulin A (local immunity marker) and surfactant protein B, responsible for reducing the alveolar surface tension.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemical synthesis
  • Anti-Inflammatory Agents / pharmacology*
  • Bronchi / drug effects*
  • Bronchi / immunology
  • Bronchi / pathology
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / immunology
  • Bronchoconstriction / drug effects
  • Bronchodilator Agents / chemical synthesis
  • Bronchodilator Agents / pharmacology*
  • Disease Models, Animal
  • Immunoglobulin A / biosynthesis
  • Male
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Neutrophils / pathology
  • Nitrogen Dioxide / administration & dosage
  • Oligopeptides / chemical synthesis
  • Oligopeptides / pharmacology*
  • Pulmonary Disease, Chronic Obstructive / chemically induced
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Pulmonary Surfactant-Associated Protein B / biosynthesis
  • Pulmonary Surfactant-Associated Protein B / immunology
  • Rats
  • Rats, Wistar
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / immunology
  • Respiratory Mucosa / pathology

Substances

  • Anti-Inflammatory Agents
  • Bronchodilator Agents
  • Immunoglobulin A
  • Oligopeptides
  • Pulmonary Surfactant-Associated Protein B
  • Nitrogen Dioxide